Abstract
Introduction NHS ambulance service conveyance rates in the UK are almost 70%, despite an increase in non-emergency cases. This is increasing the demands on crowded emergency departments (ED) and contributes to increased ambulance turnaround times. Yorkshire Ambulance Service introduced a specialist paramedic (SP) role to try and address this, but non-conveyance rates in this group have not been as high as expected.
Methods We conducted a controlled interrupted time series analysis of appropriate non-conveyance rates in the 12 months before and after an SP primary care placement, using matched groups of patients cared for by SPs and control paramedics. A costing analysis examined the average cost per appropriate non-conveyance and the cost-effectiveness ratio between groups.
Results Between June 2017 and December 2019 there were 7349 incidents attended by intervention group SPs and eligible for inclusion. Following removal of cases with missing data, 5537/7349 (75.3%) cases remained. Post-placement, the intervention group demonstrated an increase in appropriate non-conveyance rate by 35.0% (95%CI 23.8-46.2%, p<0.001) and a reduction in the trend of appropriate non-conveyance relative to the control group of −1.2% (95%CI −2.8-0.5%, p=0.156).
Post-placement, the cost per appropriate non-conveyance for intervention paramedics was a mean of £509.42 (95% bootstrapped CI £485.94-£535.41) versus £1124.41 (95% bootstrapped CI £1041.89-£1218.31) for the control group. This represents a mean saving of £615 per appropriate non-conveyance (95% bootstrapped CI £545.31-£686.69) for SPs compared to the control group, and a cost-effectiveness ratio of £1758.89 per percentage increase in appropriate non-conveyance (95% bootstrapped CI £1477-76-£2133.08).
Conclusion In this single UK NHS ambulance service study, we found a clinically important and statistically significant increase in appropriate non-conveyance rates by specialist paramedics who had completed a 10-week GP placement. This improvement persisted for the 12-month period following the placement and demonstrated cost savings compared to usual care.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04193800
Funding Statement
This paper presents independent research by the NIHR Applied Research Collaboration Yorkshire and Humber (ARC YH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK HRA and Health and Care Research Wales (HCRW) approval obtained. REC reference: 20/HRA/0006 IRAS project ID: 265560
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Permission has not been provided to make the original dataset available. However the scripts to undertake the analysis and a synthetic data set are available from the study GitHub repository: https://github.com/RichardPilbery/SPRAINED.